r Rd to:oleo ocoinike boon on XX of 400000 men io US on AD1 have moderole to more ivt norhesilthe once was Sa3C0 hoot of freemen! 8 EFTA00810559 VERU-111 may address key limitations of current prostate cancer treatments The only effective agents against advanced and metastatic prostate cancer are hor

4 (cis-clomiphene) to treat hot flashes in advanced prostate cancer patients on hormone therapy is expected to begin in Q318 with data in O119. • VERU-111 significant potential in oncology — Veru is also preparing to start a Phase 1/2 open label trial to study VERU-111, a novel, taxane-like oral thera

tant Human Prostate Cancer Model at the 2018 Annual EAU Congress To: Harry Fisch <1 Veru Announces Presentation of Data Demonstrating Efficacy of VERU-111 in a Taxane Resistant Human Prostate Cancer Model at the 2018 Annual EAU Congress MIAMI, March 16, 2018 (GLOBE NEWSWIRE) --Veru Inc. (NASDAQ:VERU)